BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23583445)

  • 1. Tristetraprolin suppresses AHRR expression through mRNA destabilization.
    Lee HH; Kim WT; Kim DH; Park JW; Kang TH; Chung JW; Leem SH
    FEBS Lett; 2013 May; 587(10):1518-23. PubMed ID: 23583445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tristetraprolin down-regulates IL-17 through mRNA destabilization.
    Lee HH; Yoon NA; Vo MT; Kim CW; Woo JM; Cha HJ; Cho YW; Lee BJ; Cho WJ; Park JW
    FEBS Lett; 2012 Jan; 586(1):41-6. PubMed ID: 22138182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'UTR AU-Rich Elements (AREs) and the RNA-Binding Protein Tristetraprolin (TTP) Are Not Required for the LPS-Mediated Destabilization of Phospholipase-Cβ-2 mRNA in Murine Macrophages.
    Shukla S; Elson G; Blackshear PJ; Lutz CS; Leibovich SJ
    Inflammation; 2017 Apr; 40(2):645-656. PubMed ID: 28124257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA.
    Kim CW; Kim HK; Vo MT; Lee HH; Kim HJ; Min YJ; Cho WJ; Park JW
    Biochem Biophys Res Commun; 2010 Sep; 400(1):46-52. PubMed ID: 20691152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tristetraprolin down-regulates IL-23 expression in colon cancer cells.
    Lee HH; Yang SS; Vo MT; Cho WJ; Lee BJ; Leem SH; Lee SH; Cha HJ; Park JW
    Mol Cells; 2013 Dec; 36(6):571-6. PubMed ID: 24292977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tristetraprolin regulates CXCL1 (KC) mRNA stability.
    Datta S; Biswas R; Novotny M; Pavicic PG; Herjan T; Mandal P; Hamilton TA
    J Immunol; 2008 Feb; 180(4):2545-52. PubMed ID: 18250465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tristetraprolin regulates prostate cancer cell growth through suppression of E2F1.
    Lee HH; Lee SR; Leem SH
    J Microbiol Biotechnol; 2014 Feb; 24(2):287-94. PubMed ID: 24150491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.
    Sanduja S; Kaza V; Dixon DA
    Aging (Albany NY); 2009 Sep; 1(9):803-17. PubMed ID: 20157568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells.
    Kim DJ; Jang JH; Ham SY; Choi SH; Park SS; Jeong SY; Kim BC; Jeon DY; Lee BJ; Ko BK; Park JW; Cho WJ
    Biochem Biophys Res Commun; 2020 Feb; 522(2):402-407. PubMed ID: 31767150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the transcriptional regulation and molecular function of the aryl hydrocarbon receptor repressor in human cell lines.
    Haarmann-Stemmann T; Bothe H; Kohli A; Sydlik U; Abel J; Fritsche E
    Drug Metab Dispos; 2007 Dec; 35(12):2262-9. PubMed ID: 17890447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.
    Jin Y; Möller E; Nord KH; Mandahl N; Von Steyern FV; Domanski HA; Mariño-Enríquez A; Magnusson L; Nilsson J; Sciot R; Fletcher CD; Debiec-Rychter M; Mertens F
    Genes Chromosomes Cancer; 2012 May; 51(5):510-20. PubMed ID: 22337624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
    Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
    Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development.
    Vogel CFA; Lazennec G; Kado SY; Dahlem C; He Y; Castaneda A; Ishihara Y; Vogeley C; Rossi A; Haarmann-Stemmann T; Jugan J; Mori H; Borowsky AD; La Merrill MA; Sweeney C
    Front Immunol; 2021; 12():625346. PubMed ID: 33763068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tristetraprolin-RNA interaction map reveals a novel TTP-RelB regulatory network for innate immunity gene expression.
    Tu Y; Wu X; Yu F; Dang J; Wei Y; Yu H; Liao W; Zhang Y; Wang J
    Mol Immunol; 2020 May; 121():59-71. PubMed ID: 32163759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.
    Leppänen T; Jalonen U; Korhonen R; Tuominen RK; Moilanen E
    Eur J Pharmacol; 2010 Feb; 628(1-3):220-5. PubMed ID: 19925787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
    Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
    Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tristetraprolin regulates the stability of HIF-1alpha mRNA during prolonged hypoxia.
    Kim TW; Yim S; Choi BJ; Jang Y; Lee JJ; Sohn BH; Yoo HS; Yeom YI; Park KC
    Biochem Biophys Res Commun; 2010 Jan; 391(1):963-8. PubMed ID: 19962963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
    Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
    Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
    Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
    Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines.
    Tsuchiya Y; Nakajima M; Itoh S; Iwanari M; Yokoi T
    Toxicol Sci; 2003 Apr; 72(2):253-9. PubMed ID: 12655030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.